Cargando…
Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines
BACKGROUND: Statins are widely prescribed to lower plasma low-density lipoprotein cholesterol levels. Though statins reduce cardiovascular disease risk overall, statin efficacy varies, and some people experience adverse side effects while on statin treatment. Statins also have pleiotropic effects no...
Autores principales: | Theusch, Elizabeth, Chen, Yii-Der I., Rotter, Jerome I., Krauss, Ronald M., Medina, Marisa W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430882/ https://www.ncbi.nlm.nih.gov/pubmed/32787775 http://dx.doi.org/10.1186/s12864-020-06966-4 |
Ejemplares similares
-
Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner
por: Theusch, E, et al.
Publicado: (2017) -
Erratum: Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner
por: Theusch, E, et al.
Publicado: (2016) -
Participant-derived cell line transcriptomic analyses and mouse studies reveal a role for ZNF335 in plasma cholesterol statin response
por: Theusch, Elizabeth, et al.
Publicado: (2023) -
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014) -
RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)